DK0828733T3 - Benzopyraner og farmaceutiske præparater indeholdende dem - Google Patents

Benzopyraner og farmaceutiske præparater indeholdende dem

Info

Publication number
DK0828733T3
DK0828733T3 DK96917431T DK96917431T DK0828733T3 DK 0828733 T3 DK0828733 T3 DK 0828733T3 DK 96917431 T DK96917431 T DK 96917431T DK 96917431 T DK96917431 T DK 96917431T DK 0828733 T3 DK0828733 T3 DK 0828733T3
Authority
DK
Denmark
Prior art keywords
benzopyrans
pharmaceutical preparations
preparations containing
pharmaceutical
preparations
Prior art date
Application number
DK96917431T
Other languages
Danish (da)
English (en)
Inventor
W Manley Paul
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0828733(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0828733T3 publication Critical patent/DK0828733T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96917431T 1995-05-24 1996-05-24 Benzopyraner og farmaceutiske præparater indeholdende dem DK0828733T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds
PCT/EP1996/002257 WO1996037490A1 (en) 1995-05-24 1996-05-24 Benzopyrans and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK0828733T3 true DK0828733T3 (da) 2001-12-17

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96917431T DK0828733T3 (da) 1995-05-24 1996-05-24 Benzopyraner og farmaceutiske præparater indeholdende dem

Country Status (31)

Country Link
US (1) US5905156A (xx)
EP (1) EP0828733B1 (xx)
JP (1) JPH11505820A (xx)
KR (1) KR100437981B1 (xx)
CN (1) CN1077888C (xx)
AR (1) AR004489A1 (xx)
AT (1) ATE205204T1 (xx)
AU (1) AU703276B2 (xx)
BR (1) BR9609048A (xx)
CA (1) CA2217821C (xx)
CO (1) CO4700520A1 (xx)
CZ (1) CZ294474B6 (xx)
DE (1) DE69615019T2 (xx)
DK (1) DK0828733T3 (xx)
ES (1) ES2163634T3 (xx)
FI (1) FI973992A (xx)
GB (1) GB9510477D0 (xx)
HK (1) HK1014137A1 (xx)
HU (1) HU222772B1 (xx)
IL (1) IL118382A (xx)
MY (1) MY114924A (xx)
NO (1) NO314846B1 (xx)
NZ (1) NZ309765A (xx)
PL (1) PL184144B1 (xx)
PT (1) PT828733E (xx)
RU (1) RU2160735C2 (xx)
SK (1) SK283215B6 (xx)
TR (1) TR199701417T1 (xx)
TW (1) TW421646B (xx)
WO (1) WO1996037490A1 (xx)
ZA (1) ZA964209B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
US7098340B2 (en) 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(n-메틸치환술폰아미도)메틸-2h-1-벤조피란 유도체
KR20180067561A (ko) 2015-09-28 2018-06-20 제넨테크, 인크. 치료 화합물 및 그의 사용 방법
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) 2017-03-24 2020-04-16 ジェネンテック, インコーポレイテッド ナトリウムチャネル阻害剤としての4−ピペリジン−n−(ピリミジン−4−イル)クロマン−7−スルホンアミド誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (xx) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
EP0828733B1 (en) 2001-09-05
HU222772B1 (hu) 2003-10-28
ATE205204T1 (de) 2001-09-15
DE69615019T2 (de) 2002-06-06
CO4700520A1 (es) 1998-12-29
JPH11505820A (ja) 1999-05-25
KR19990021925A (ko) 1999-03-25
CA2217821A1 (en) 1996-11-28
BR9609048A (pt) 1999-02-23
IL118382A0 (en) 1996-09-12
DE69615019D1 (de) 2001-10-11
ZA964209B (en) 1997-11-24
HUP9801751A3 (en) 1999-08-30
GB9510477D0 (en) 1995-07-19
CN1077888C (zh) 2002-01-16
US5905156A (en) 1999-05-18
NO975365D0 (no) 1997-11-21
NO314846B1 (no) 2003-06-02
AR004489A1 (es) 1998-12-16
TW421646B (en) 2001-02-11
HK1014137A1 (en) 1999-09-24
EP0828733A1 (en) 1998-03-18
PL184144B1 (pl) 2002-09-30
NO975365L (no) 1998-01-15
ES2163634T3 (es) 2002-02-01
KR100437981B1 (ko) 2004-07-16
PT828733E (pt) 2002-02-28
IL118382A (en) 2000-01-31
NZ309765A (en) 2000-01-28
TR199701417T1 (xx) 1998-02-21
AU703276B2 (en) 1999-03-25
CN1185153A (zh) 1998-06-17
WO1996037490A1 (en) 1996-11-28
CA2217821C (en) 2008-05-06
FI973992A0 (fi) 1997-10-17
AU6000896A (en) 1996-12-11
FI973992A (fi) 1997-12-09
CZ368897A3 (cs) 1998-02-18
SK283215B6 (sk) 2003-03-04
MY114924A (en) 2003-02-28
PL324042A1 (en) 1998-05-11
HUP9801751A2 (hu) 1999-06-28
RU2160735C2 (ru) 2000-12-20
SK157797A3 (en) 1998-05-06
CZ294474B6 (cs) 2005-01-12
MX9709004A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
DK0835246T3 (da) Aromatiske forbindelser og farmaceutiske præparater, der indeholder dem
IL139235A0 (en) Pharmaceutical preparations
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
FI973278A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
DK0826673T3 (da) Acetamidderivater, fremgangsmåde til fremstilling deraf og medicinske præparater
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
NO954146D0 (no) Belagte farmasöytiske preparater
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DE69625368D1 (de) Schweisshemmende deodorierende präparaten
NO965376D0 (no) Farmasötiske preparater og metoder for formulering av signaltransduksjon
KR960700239A (ko) 크로만 유도체 및 그의 제약학적 용도(chroman derivative and medicinal use thereof)
NO307925B1 (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO976128L (no) Forbindelser og farmasöytiske blandinger som inneholder dem
NO975984L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
HUP9603071A2 (en) Purin-6-one derivatives and pharmaceuticals preparations containing them
BR9610396A (pt) Formulação farmacêutica
NO965102L (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK0828733T3 (da) Benzopyraner og farmaceutiske præparater indeholdende dem
DK0565105T3 (da) Forgrenede cyclodextriner og fremgangsmåder til fremstilling heraf
DK1288203T3 (da) Cykliske nitroner og farmaceutiske præparater, der indeholder dem
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof